Φορτώνει......
Clodronate for treatment of bone metastases in hormone refractory prostate cancer
INTRODUCTION: Approximately 85% of patients who die from prostate cancer have bone metastases. Even though the radiological aspect of such metastases is osteoblastic, we currently know that these lesions are mixed, with coexisting blastic and lytic lesions, always beginning with bone lysis by osteoc...
Αποθηκεύτηκε σε:
| Κύριοι συγγραφείς: | , , |
|---|---|
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Sociedade Brasileira de Urologia
2003-06-01
|
| Σειρά: | International Brazilian Journal of Urology |
| Θέματα: | |
| Διαθέσιμο Online: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382003000300006 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|